
Results
7
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
7 companies
Neuland Laboratories
Market Cap: ₹221.0b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹17,456.50
7D
-2.0%
1Y
12.3%
Aether Industries
Market Cap: ₹102.5b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹838.90
7D
14.0%
1Y
2.7%
Senores Pharmaceuticals
Market Cap: ₹36.5b
Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.
SENORES
₹780.40
7D
-5.2%
1Y
n/a
Sai Life Sciences
Market Cap: ₹182.8b
Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.
SAILIFE
₹871.95
7D
-0.4%
1Y
n/a
Granules India
Market Cap: ₹134.9b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally.
532482
₹546.95
7D
-1.4%
1Y
2.4%
Indoco Remedies
Market Cap: ₹24.7b
Manufactures and markets formulations and active pharmaceutical ingredients in India and internationally.
INDOCO
₹262.90
7D
0.7%
1Y
-15.1%
Laurus Labs
Market Cap: ₹538.2b
Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
LAURUSLABS
₹999.00
7D
1.7%
1Y
105.6%